130
Views
11
CrossRef citations to date
0
Altmetric
Original Research

A radiologic-laparoscopic model to predict suboptimal (or complete and optimal) debulking surgery in advanced ovarian cancer: a pilot study

, , , , , & show all
Pages 333-342 | Published online: 28 May 2019

References

  • Adams S, Leveson S. Clinical prediction rules. BMJ. 2012;344. doi:10.1136/bmj.d8312
  • McGinn TG, Guyatt GH, Wyer PC et al; Evidence-Based Medicine Working Group. Users’ guides to the medical literature: XXII: how to use articles about clinical decision rules. JAMA. 2000;284:79–84. doi:10.1001/jama.284.1.7910872017
  • Justice A. Assessing the generalizability of prognostic information. Ann Intern Med. 1999;130:515–524.10075620
  • Saitou M, Iida Y, Komazaki H, et al. Success rate and safety of tumor debulking with diaphragmatic surgery for advanced epithelial ovarian cancer and peritoneal cancer. Arch Gynecol Obstet. 2015;291:641–646. doi:10.1007/s00404-014-3446-725182215
  • Llueca A, Escrig E. Prognostic value of peritoneal cancer index in primary advanced ovarian cancer. Eur J Surg Oncol. 2017. doi:10.1016/j.ejso.2017.11.003
  • Llueca A, Serra A, Rivadulla I, Gomez L, Escrig J; MUAPOS working group (Multidisciplinary Unit of Abdominal Pelvic Oncology Surgery). Prediction of suboptimal cytoreductive surgery in patients with advanced ovarian cancer based on preoperative and intraoperative determination of the peritoneal carcinomatosis index. World J Surg Oncol. 2018;16:37. doi:10.1186/s12957-018-1339-029471831
  • Jacquet P, Sugarbaker PH. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Peritoneal carcinomatosis: principles of management. Cancer Treat Res. 1996;82:359–374.8849962
  • Clavien PA, Sanabria JR, Strasberg SM. Proposed classification of complications of surgery with examples of utility in cholecystectomy. Surgery. 1992;111:518–526.1598671
  • Rustin GJ, Quinn M, Thigpen T, et al. Re:new guidelines to evaluate the response to treatment in solid tumors (ovarian cancer). J Natl \Cancer Inst. 2004;96:487–488. doi:10.1093/jnci/djh081
  • Spiegelhalter DJ, Knill-Jones RP. Statistical and knowledge-based approaches to clinical decision-support systems, with an application in gastroenterology. J R Stat Soc Ser A Stat Soc. 1984;147:35–77. doi:10.2307/2981737
  • Seymour DG, Green M, Vaz FG. Making better decisions: construction of clinical scoring systems by the Spiegelhalter-Knill-Jones approach. BMJ. 1990;300:223–226. doi:10.1136/bmj.300.6719.2232106929
  • Ibeanu OA, Bristow RE. Predicting the outcome of cytoreductive surgery for advanced ovarian cancer. Int J Gynecol Cancer. 2010;10:S1–S11. doi:10.1111/IGC.0b013e3181cff38b
  • Wimberger P, Lehmann N, Kimmig R, et al. Prognostic factors for complete debulking in advanced ovarian cancer and its impact on survival: an exploratory analysis of a prospectively randomized phase III study of the Arbeitsgeme in schaftGynaekologischeOnkologie Ovarian Cancer Study Group (AGO-OVAR). Gynecol Oncol. 2007;106:69–74.17397910
  • Llueca JA, Herraiz JL, Catala C, et al; MUAPOS Working Group. Effectiveness and safety of cytoreduction surgery in advanced ovarian cancer: initial experience at a university general hospital. J Clin Gynecol Obstet. 2015;4:251–257. doi:10.14740/jcgo345w
  • Lombardo S, Espejo JJ, López C, et al. Peritoneal cancer indexes in ovarian carcinomatosis: correlation between CT and intraoperative results and survival. Is CT a good tool for correlation? Clin Surg. 2016;1:1209.
  • Nelson BE, Rosenfield AT, Schwartz PE. Pre-operative abdominopelvic computed tomographic prediction of optimal cytoreduction in epithelial ovarian cancer. J Clin Oncol. 1993;11:166–172. doi:10.1200/JCO.1993.11.12.24118418230
  • Meyer JI, Kennedy AW, Friedman R, et al. Ovarian carcinoma: value of CT in predicting success of debulking surgery. AJR. 1995;165:875–878.7676985
  • Dowdy SC, Mullany SA, Brandt KR, et al. The utility of computed tomography scans in predicting suboptimal cytoreductive surgery in women with advanced ovarian cancer. Cancer. 2004;101:346–352. doi:10.1002/cncr.2037615241833
  • Fagotti A, Ferrandina G, Fanfani F, et al. A laparoscopy-based score to predict surgical outcome in patients with advanced ovarian carcinoma: a pilot study. Ann Surg Oncol. 2006;13:1156–1161. doi:10.1245/ASO.2006.08.02116791447
  • Eisenkop SM, Spirtos NM, Friedman RL, et al. Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: a prospective study. Gynecol Oncol. 2003;90:390–396. doi:10.1016/S0090-8258(03)00278-612893206
  • Harmon RL, Sugarbaker PH. Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer. Int Semin Surg Oncol. 2005;8:2–3.
  • Brun J, Rouzier R, Uzan S, et al. External validation of a laparoscopic-based score to evaluate resectability of advanced ovarian cancers: clues for a simplified score. Gynecol Oncol. 2008;110:354–359. doi:10.1016/j.ygyno.2008.04.04218572226
  • Petrillo M, Vizzielli G, Fanfani F, et al. Definition of a dynamic laparoscopic model for the prediction of incomplete cytoreduction in advanced epithelial ovarian cancer: proof of a concept. Gynecol Oncol. 2015;139:5–9. doi:10.1016/j.ygyno.2015.07.09526196319
  • Deffieux X, Castaigne D, Pomel C. Role of laparoscopy to evaluate candidates for complete cytoreduction in advanced stages of epithelial ovarian cancer. Int J Gynecol Cancer. 2006;16(Suppl 1):35–40. doi:10.1136/ijgc-00009577-200602001-0000616515565
  • Chéreau E, Ballester M, Selle F, et al. Comparison of peritoneal carcinomatosis scoring methods in predicting resectability and prognosis in advanced ovarian cancer. Am J Obstet Gynecol. 2010;201:178.e1–10. doi:10.1016/j.ajog.2009.10.856
  • Tucker SL, Gharpure K, Herbrich SM, et al. Molecular biomarkers of residual disease after surgical debulking of high-grade serous ovarian cancer. Clin Cancer Res. 2014;20:3280–3288. doi:10.1158/1078-0432.CCR-13-304524756370
  • Suidan RS, Ramirez PT, Sarasohn DM, et al. A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancer. Gynecol Oncol. 2014;134:468–472. doi:10.1016/j.ygyno.2014.07.09025042672